Arvinas ARVN
NASDAQ ARVN
$9.39 +0.07 (+0.81%)
As of: Sep 4, 2026 · 3:12 PM EDT

Arvinas (ARVN) Net Margin (2017 - 2026)

Arvinas (ARVN) posted quarterly Net Margin of 369.23% for Q1 2026, down 41314.0% year-over-year from N/an in Q1 2025, and up 47.96% quarter-over-quarter from 709.47% in Q4 2025.

Analysis

Arvinas (ARVN) Net Margin (2017 - 2026) Analysis & Trends

Arvinas' Net Margin history runs 10 years deep, the most recent figure standing at 369.23% for Q1 2026.

  • In Q1 2026, Net Margin fell 41314.0% year-over-year to 369.23%; the TTM figure through Mar 2026 stood at 247.54% (down 23662.0% YoY), while the FY2025 annual figure was 30.77%, up 4474.0% from the prior year.
  • Net Margin for Q1 2026 stood at 369.23%, up from 709.47% in the prior quarter.
  • The five-year high for Net Margin was 359.16% in Q4 2023, with the low at 709.47% in Q4 2025.
  • The 5-year median for Net Margin is 190.66% (2022), against an average of 168.42%.
  • The sharpest annual moves came in 2022 and 2025: Net Margin soared 71484 bps in 2022, then slumped 63329 bps in 2025.
  • Arvinas' Net Margin stood at 211.9% in 2022, then soared by 269 bps to 359.16% in 2023, then tumbled by 121 bps to 76.18% in 2024, then sank by 831 bps to 709.47% in 2025, then soared by 48 bps to 369.23% in 2026.
  • Business Quant data shows ARVN's Net Margin at 369.23% in Q1 2026, 709.47% in Q4 2025, and 83.77% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 30.23%
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 31.16%
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -539.31%
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 13.90%
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 12.74%
8 Royalty Pharma 28.43 Bn 27.59 Bn - 12.09%
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.12%
10 Arvinas 608.15 Mn 40.25 Mn - 67.84%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.84%
Mar 31, 2026 -369.23%
Dec 31, 2025 -709.47%
Sep 30, 2025 -83.77%
Jun 30, 2025 -273.21%
Mar 31, 2025 43.91%
Dec 31, 2024 -76.18%
Sep 30, 2024 -48.05%
Jun 30, 2024 -46.01%
Mar 31, 2024 -274.31%
Dec 31, 2023 359.16%
Sep 30, 2023 -184.68%
Jun 30, 2023 -119.82%
Mar 31, 2023 -248.62%
Dec 31, 2022 -211.90%
Sep 30, 2022 -190.66%
Jun 30, 2022 -199.70%
Mar 31, 2022 -230.57%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%